Article info
PDFClinical and epidemiological research
Extended report
Identification of novel antiacetylated vimentin antibodies in patients with early inflammatory arthritis
- Correspondence to Professor Karim Raza, Research Laboratories, Centre for Translational Inflammation Research, University of Birmingham, Queen Elizabeth Hospital. Birmingham B15 2WB, UK; K.Raza{at}bham.ac.uk
Citation
Identification of novel antiacetylated vimentin antibodies in patients with early inflammatory arthritis
Publication history
- Received October 13, 2014
- Revised May 13, 2015
- Accepted May 14, 2015
- First published July 9, 2015.
Online issue publication
October 31, 2019
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
- Data supplement 1 - Online supplement
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/